Study of Two Formulations of Cyclosporine Ophthalmic Emulsion in Healthy Volunteers and in Patients With Dry Eye
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, tolerability and pharmacokinetics of two formulations of
cyclosporine ophthalmic emulsion in healthy adults (parallel-group phase). The parallel-group
phase will be followed by a paired-eye phase which will evaluate the safety and tolerability
of two formulations of cyclosporine ophthalmic emulsion compared with cyclosporine ophthalmic
emulsion (RESTASIS®) in patients with dry eye.